Search

everythinglearnresearchcommunity

for

Search:↓

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Niacin deficiency makes rats more sensitive to cancer-causing chemicals.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Hydrogel microneedles offer a promising, minimally invasive way to treat diseases like cancer and hair loss, but need improvements in strength and standardization.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

The hedgehog signalling pathway is key in skin development and basal cell carcinoma, offering insights for prevention and treatment.